Drug firm AstraZeneca Pharma India on Monday reported a 8.21 per cent dip in net profit at Rs 26.70 crore for the quarter ended December.
The company had posted a net profit of Rs 29.09 crore in the corresponding period of the previous fiscal, it said in a filing to the BSE.
Revenue from operations stood at Rs 223.86 crore for the quarter under consideration as compared with Rs 215.19 crore for the same period a year ago.
Shares of AstraZeneca Pharma India on Monday closed 0.07 per cent lower at Rs 2,610.85 per scrip on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
